APA (7th ed.) Citation

O, G., C, L., AK, S., J, G., N, S., GS, C., . . . N, S. (2022). Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies. Transfusion, 62(5), 1089. https://doi.org/10.1111/trf.16826

Chicago Style (17th ed.) Citation

O, Gajic-Veljanoski, et al. "Cost-effectiveness of Noninvasive Fetal RhD Blood Group Genotyping in Nonalloimmunized and Alloimmunized Pregnancies." Transfusion 62, no. 5 (2022): 1089. https://doi.org/10.1111/trf.16826.

MLA (9th ed.) Citation

O, Gajic-Veljanoski, et al. "Cost-effectiveness of Noninvasive Fetal RhD Blood Group Genotyping in Nonalloimmunized and Alloimmunized Pregnancies." Transfusion, vol. 62, no. 5, 2022, p. 1089, https://doi.org/10.1111/trf.16826.